Gilead Sciences, Inc. (GILD) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 152.69B |
| Enterprise Value | 170.06B |
| P/E Ratio | -51.23 |
| PEG Ratio | 0.34 |
| Price/Sales Ratio | 5.43 |
| Price/Book Ratio | 14.1 |
| Enterprise/Revenue | 5.41 |
| Enterprise/EBITDA | 258.84 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -0.11 |
| Operating Margin | -0.05 |
| Return On Assets | -0.07 |
| Return On Equity | -0.16 |
| Revenue | 29.44B |
| Revenue/Share | 24.5 |
| Gross Profit | 23.21B |
| EBITDA | 13.58B |
| Net Income | 8.51B |
| Diluted EPS | 6.78 |
| Total Cash | 3.18B |
| Total Cash/Share | 2.56 |
| Total Debt | 2.41B |
| Total Debt/Equity | 0.21 |
| Current Ratio | 1.14 |
| Book Value Per Share | 9.45 |
| 52-Week Change | 10.58 |
| 52-Week High | 157.29 |
| 52-Week Low | 108.46 |
| Moving Average 50 Days | 129.72 |
| Moving Average 200 Days | 132.08 |
| Average Volume | 7.73M |
| Shares Outstanding | 1.24B |
| % Held by Institutions | 86.2 |
| Trailing Annual Dividend Rate | 3.22 |
| Trailing Annual Dividend Yield | 2.42 |
| Payout Ratio | -1.26 |
| Last Split Factor | 2:1 |
| Last Split Date | January 28, 2013 |